Potential molecular mechanism of Yishen capsule in the treatment of diabetic nephropathy based on network pharmacology and molecular docking technology
Yaling Hu(Shanxi Medical University), Jingai Fang(Shanxi Medical University)
Cited by 0
Related Papers
miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A
|Clinical Cancer Research|2014|204
MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1
|Protein & Cell|2014|89
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
|Journal of Chinese Integrative Medicine|2021|6
Correction to: MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1
|Protein & Cell|2021|1
P0394EFFICACY AND SAFETY OF A CHINESE PATENT MEDICINE-SHENYANKANGFU TABLETS FOR PRIMARY GLOMERULONEPHRITIS:A RANDOMISED CONTROLLED TRIAL
|Nephrology Dialysis Transplantation|2020|0